Garczorz W, Gallego-Colon E, Kosowska A, Kych-Ratuszny A, Woniak M, Marcol W, et al
doi: 10.1056/NEJM199908193410801 83
Pedro MT, Antonidias G, Scheuerle A, et al
Further support for the understanding that free carnitine availability may limit fat oxidation comes from Achten & Jeukendrup, (2004)
GLP-1 Drugs Linked to Reduced Risk of Depression and Bipolar Disorder According to a new study published in Translational Psychiatry , lifelong genetic activation of the glucagon-like peptide-1 receptor (GLP-1R) was linked with better mental well-being and significantly lower odds of major depressive disorder and bipolar disorder